Several blood biomarkers, such as carbohydrate antigen 19-9 (CA 19-9), carcinoembryonic antigen (CEA), lactate dehydrogenase, caveolin-1, C-reactive protein, and cathepsin L, have prognostic importance in pancreatic cancer.[6–9]. This evidence concerns the gene CEACAM5 and familial pancreatic carcinoma.